DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
Year | Capital Work in Progress |
---|---|
Mar2025 | ₹1,022 Cr |
Mar2024 | ₹778 Cr |
Mar2023 | ₹212 Cr |
Mar2022 | ₹470 Cr |
Mar2021 | ₹711 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2025 | ₹1,022 Cr | 31.36 | |
Mar2024 | ₹778 Cr | 266.98 | |
Mar2023 | ₹212 Cr | -54.89 | |
Mar2022 | ₹470 Cr | -33.87 | |
Mar2021 | ₹711 Cr | - |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹160,004.9 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹106,486.0 Cr | 0.1% | 6.1% | 6.2% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 0% |
1.1% |
10.7% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses